Baidu
map

TISOTUMAB VEDOTIN YIELDS RESPONSES AS SECOND-LINE CERVICAL CANCER THERAPY

[Anonymous]

CANCER DISCOVERY, 2021; 11 (6): 1319

Baidu
map
Baidu
map
Baidu
map